Prostate cancer survival rates improve as more men come forward
Improved prostate cancer survival rates reported
33 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 33 separate news trends connected to Prostate Cancer, spanning June 21, 2026 through October 8, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 301 article observations and 282 source signals, led by Health, Entertainment, Science coverage. Use it to compare how individual events emerged, spread and changed over time.
Improved prostate cancer survival rates reported
tRNA dosage linked to prostate cancer resistance and aggression
Radiotherapy found as effective as surgery for localized prostate cancer treatment
A routine checkup meant to confirm peak fitness revealed a shocking prostate cancer diagnosis at age 33, sparking calls for earlier screening.
Men’s regret over missed prostate warning signs fuels a wave of early‑screening advocacy during Prostate Cancer Awareness Month
11 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
4 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
A San Diego veteran’s terminal diagnosis sparks a wave of anxiety, pushing men to confront prostate cancer screening during Awareness Month
A fresh study exposing men's low awareness of dairy's link to prostate cancer puts public health and dairy markets under new scrutiny.
Rising prostate cancer diagnoses clash with new advice that many early cases need no immediate treatment.
A blood test that identified Jeremy Clarkson's prostate cancer is now slated for 10,000 men, sparking debate over screening policy
Integrated mutational signatures map DNA damage pathways, offering a new lens on aggressive prostate cancer.
Microbes in men’s urinary tracts can synthesize testosterone, shaking assumptions about hormone sources and prostate health.
Exercise prescribed for prostate cancer patients to reduce treatment side effects, study says.
New prostate‑cancer screening tools promise earlier detection, sparking a wave of public‑health campaigns across the US.
Rising prostate cancer rates and September’s awareness push have health outlets urging men to act now on screening.
A 3 % yearly rise in prostate cancer and more late‑stage diagnoses are driving urgent calls for men over 50 to get screened.
New research reveals how prostate tumors adapt to evade hormone therapy, affecting treatment outcomes for patients.
New data on prostate cancer treatment has divided physicians, with active surveillance rates rising and focal therapy use under scrutiny.
A new study indicates that MRI scans may eliminate the necessity for invasive biopsies in diagnosing prostate cancer for many patients.
Men over 50 in the UK will no longer be automatically entitled to prostate cancer blood tests.
Recent research links the consumption of ultra-processed foods commonly found in American diets to an elevated risk of developing prostate cancer.
New research suggests that prostate-specific antigen levels below a certain threshold may predict prostate cancer prognosis.
Health experts and medical organizations are highlighting the necessity of recognizing early prostate cancer symptoms to encourage timely medical screening.
Researchers are using CRISPR gene-editing technology to re-sensitize prostate tumors to immunotherapy treatments.
Researchers have developed a fully human antibody drug capable of halting the growth and metastasis of aggressive prostate cancer in lab models.
Medical professionals and health outlets highlight the critical role of early detection and robotic surgery in treating rising prostate cancer cases.
A study from Imperial College Healthcare NHS Trust indicates focal therapy for prostate cancer matches surgery and radiotherapy in efficacy.
New data suggests a second PSMA PET scan can alter treatment plans for nearly half of patients with prostate cancer.
A new blood test called Stockholm3 is outperforming traditional PSA screenings by detecting 90% of aggressive prostate cancer cases.
A new multicomponent blood test is demonstrating higher detection rates for clinically significant prostate cancer compared to traditional PSA testing.
The NHS is expanding access to high-powered radiotherapy for thousands of men with prostate cancer to reduce treatment times.
Jeremy Clarkson is urging the public to seek medical screenings after revealing his battle with aggressive prostate cancer.